Nuvalent NUVL
NUVL
$123.96 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Nuvalent (NUVL) Amortizatization of Intangibles (2021 - 2026)

Nuvalent's (NUVL) quarterly Amortizatization of Intangibles came in at $1.8 million in Q1 2026, down 57.27% YoY from $4.3 million in Q1 2025, and down 90.98% on a QoQ basis from $20.3 million in Q4 2025.

Analysis

Nuvalent (NUVL) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends

Nuvalent (NUVL) has 6 years of Amortizatization of Intangibles data on file, last reported at $1.8 million in Q1 2026.

  • Quarterly Amortizatization of Intangibles fell 57.27% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.7 million (down 61.25% YoY) and the FY2025 annual result came in at $11.1 million, down 24.28% from the prior year.
  • Amortizatization of Intangibles slipped to $1.8 million in Q1 2026, from $20.3 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $24.4 million in Q4 2024 to a low of -$11.3 million in Q2 2025.
  • A 5-year average of $2.2 million and a median of -$833000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
  • The widest YoY moves for Amortizatization of Intangibles: up 2275.99% in 2023, down 87566.67% in 2023.
  • Tracing NUVL's Amortizatization of Intangibles over 5 years: stood at -$833000.0 in 2022, then surged by 2275.99% to $18.1 million in 2023, then surged by 34.64% to $24.4 million in 2024, then retreated by 16.89% to $20.3 million in 2025, then plunged by 90.98% to $1.8 million in 2026.
  • The last three Amortizatization of Intangibles figures came in at $1.8 million (Q1 2026), $20.3 million (Q4 2025), and -$2.2 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 Nuvalent 9.75 Bn 9.75 Bn - 1.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.83 Mn
Dec 31, 2025 20.28 Mn
Sep 30, 2025 -2.19 Mn
Jun 30, 2025 -11.27 Mn
Mar 31, 2025 4.28 Mn
Dec 31, 2024 24.41 Mn
Sep 30, 2024 -2.92 Mn
Jun 30, 2024 -3.43 Mn
Mar 31, 2024 -3.38 Mn
Dec 31, 2023 18.13 Mn
Sep 30, 2023 -2.63 Mn
Jun 30, 2023 -2.85 Mn
Mar 31, 2023 -2.54 Mn
Dec 31, 2022 -833,000.00
Sep 30, 2022 -3,000.00
Jun 30, 2022 187,000.00
Mar 31, 2022 276,000.00
Dec 31, 2021 214,000.00
Sep 30, 2021 1,000.00